GCKR is a NAFLD susceptibility gene that encodes liver-specific glucokinase regulatory protein (GKRP), which plays an important role in de novo lipogenesis and development of NAFLD (Donnelly et al., 2005; Brouwers et al., 2015). This evidence concerns the gene GCKR and metabolic dysfunction-associated steatotic liver disease.